A Fenac 1%
Company | Acme Laboratories Ltd. | |
---|---|---|
Active Ingredient | ![]() | |
Variants |
|
Dose
Gel: For external use only. Depending on the size of area to be treated, 2-4 g of Gel should be applied to the skin 3-4 times daily. To the affected area gel should be rubbed in lightly.
Gel may also be given in addition to further treatment with other dosage forms of Diclofenac.
Alternative Brands to A Fenac 1%
Indication
Rheumatoid arthritis, Osteoarthritis, Joint and muscular pains
Contra Indication
Contraindicated to the patients hypersensitive to any ingredient of the products. Peptic ulcer, hypersensitivity to Diclofenac like other non-steroid anti-inflammatory agents, Diclofenac is also contra-indicated in asthmatic patient in whom attack with asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs with prostaglandin synthetase inhibitor. Gel should not be used under occlusive airtight dressings.
Side Effect
Generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Gel may cause local irritation and reddening of the skin and skin rash.
Interaction
May increase serum levels of methotrexate. Concomitant use w/ other NSAIDs or anticoagulants (e.g. warfarin) is associated w/ higher risk of GI bleeding. Increased risk of nephrotoxicity w/ ciclosporin or triamterene. May increase the risk of developing corneal complications in patients w/ significant pre-existing corneal inflammation when use concomitantly w/ ophth preparation containing corticosteroids. Colestyramine and colestipol reduce the bioavailability of diclofenac. Decreased plasma concentration when administered after sucralfate. Ophth application of diclofenac may reduce the efficacy of ophth acetylcholine and carbachol. May increase serum levels of lithium and digoxin.
Therapeutic Classes
- Topical Analgesics
- Topical anti-inflammatory preparations
Indicaitons
- Osteoarthritis / degenerative arthritis
- Backache
- Back pain
- Pain and joint stiffness
- Joint and muscular pains
- Bursitis
- Local pain relief
- Rheumatoid Arthritis (RA)
Precaution
In rare instances where peptic ulceration or gastro-intestinal bleeding occurs in patients under treatment with Diclofenac. In patients with advanced age should be kept under close observation.Gel should not be allowed to come in contact with the eyes or mucus membranes, after application the hands should be washed properly and not to be taken by mouth.
Mode of Action
Diclofenac, a phenylacetic acid derivative is a prototypical NSAID. It has potent anti-inflammatory, analgesic and antipyretic actions. Inhibits cyclooxygenase (COX)-1 and COX-2, thereby inhibiting prostaglandin synthesis. May also inhibit neutrophil aggregation/activation, inhibit chemotaxis, decrease proinflammatory cytokine level, and alter lymphocyte activity.